Global Microarray Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Microarray Market” is an upcoming report by MarketResearch.biz. The global microarray market segmentation allows for deeper understanding and thought, to decisively assess, analyze, and study. Besides revenues for segments, global, regional, and country-wise, market revenue segmentation will be compiled in a fastidious manner for clear flow and understanding. The analysis will be conducted using expert opinions and inputs, as well as thorough primary and secondary research efforts to determine various aspects of the microarray market. The global microarray market report will be segmented on the basis of product, type, application, end-use, and region.
A microarray is a laboratory tool that is used to detect the expression of thousands of genes simultaneously. DNA microarrays are microscope slides that are printed with numerous tiny spots in defined positions, with each spot containing picomoles of a specific DNA sequence known as probes.
Microarrays have a vast array of applications and are now finding prominent usage in toxicological response profiling, biomarker identification, basic molecular biology, and pharmaceutical target screening.
The increasing incidence of cancer is one of several factors that are propelling market growth in recent years. A subsequent increase in healthcare R&D is projected to offer a significant boost to market growth. The increasing usage of microarrays in applications such as genotyping, measuring predisposition to disease, forensic analysis, evaluating somatic mutations in cancers or germline mutations in individuals, assessing loss of heterozygosity, etc. are projected to fuel market growth over the foreseeable future.
Factors that could hinder the global microarray market growth are the expeditious advances of next-generation DNA sequencing that are proven to be more cost-effective and accurate, coupled with stringent government regulations, a lack of skilled professionals, and the standardization of microarray data.
In terms of product, the market is segmented into consumables, software & services, and instruments. Bulk and repeat purchase of the consumables segment for diverse applications can be attributed as the primary factor for its majority revenue share and this is projected to continue over the foreseeable future.
With respect to microarray type, the market is categorized into DNA, and protein among others. The DNA microarray accounted for the majority revenue share in 2018 due to its vast range of applications such as transcription binding analysis, genotyping, and gene expression analysis among others.
The increase in the adoption of protein microarrays by biopharmaceutical and pharmaceutical companies for toxicology and drug discovery studies is expected to fuel future market growth. The ‘others’ microarray applications also account for a significant percentage of the global microarray market.
The application aspect of the market is segmented into drug discovery, research applications, disease diagnostics and other applications like proteomic, genomic, and toxicological research.
With respect to end-use, the market is categorized into – diagnostic laboratories, research & academic institutions, and pharmaceutical & biotechnology companies among others. The research & academic institutions segment accounted for the majority revenue share in 2018 owing to an increase in the implementation of microarrays in research and drug discovery applications. Pharmaceutical & biotechnology companies as well as diagnostic laboratories are expected to contribute to the overall growth of the global microarray market.
The market in North America accounted for a majority revenue share in 2018 due to an increase in the number of cancer patients in the US. The market in Europe is expected to receive significant investments meant for R&D in the coming years. And, the Asia Pacific market is projected to expand significantly over the forecast period due to an increase in government funding for the healthcare sector.
Global Market Segmentation:
Global market segmentation, by Product:
- Software and Services
Global market segmentation, by Type:
- DNA Microarrays
- Protein Microarrays
- Other Microarrays
Global market segmentation, by Application:
- Research Applications
- Drug Discovery
- Disease Diagnostics
- Other Applications
Global market segmentation, by End-use:
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Users
Global market segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Bio-Rad Laboratories
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- PerkinElmer Inc.
- Merck KGaA
- GE Healthcare
- Molecular Devices, LLC
- Arrayit Corporation
- Microarrays Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!